Fairmount Funds Management’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89M | Hold |
2,048,647
| – | – | 11.53% | 1 |
|
|
2025
Q1 | $76.5M | Hold |
2,048,647
| – | – | 11.87% | 2 |
|
|
2024
Q4 | $92.8M | Hold |
2,048,647
| – | – | 9.23% | 4 |
|
|
2024
Q3 | $120M | Hold |
2,048,647
| – | – | 9.76% | 3 |
|
|
2024
Q2 | $80.6M | Hold |
2,048,647
| – | – | 9.11% | 4 |
|
|
2024
Q1 | $136M | Sell |
2,048,647
-892,529
| -30% | -$59.3M | 14.84% | 3 |
|
|
2023
Q4 | $82.2M | Hold |
2,941,176
| – | – | 8.68% | 4 |
|
|
2023
Q3 | $62.6M | Buy |
+2,941,176
| New | +$62.6M | 7.54% | 4 |
|